Erik Holmlin, President and CEO of BioNano Genomics Inc., with the company’s genome-mapping platform Irys System.

Erik Holmlin, President and CEO of BioNano Genomics Inc., with the company’s genome-mapping platform Irys System. Photo by Stephen Whalen.

In an era of personalized medicine, customized gene mapping is crucial for drug developers and researchers to match the right treatments to the right patients — which is why San Diego-based BioNano Genomics Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129